Issued Patents 2019
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10406179 | Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling | Judith A. Shizuru, Kipp Andrew Weiskopf, Aaron Michael Ring, Akanksha Chhabra, Peter Schnorr | 2019-09-10 |
| 10386361 | Long term hematopoietic stem cell specific reporter mouse and uses thereof | James Y. Chen, Masanori Miyanishi | 2019-08-20 |
| 10358472 | High affinity CD47 analogs | Chia Chi Ho, Kenan Christopher Garcia, Aaron Michael Ring, Kipp Andrew Weiskopf, Nan Guo Ring | 2019-07-23 |
| 10344094 | Treatment of cancer with dual targeting of CD47 and EGFR | Stephen Willingham, Doris Po Yi Ho, Piero D. Dalerba, Kelly Marie McKenna, Jens-Peter Volkmer | 2019-07-09 |
| 10329354 | Modulation of efferocytosis pathways for treatment of atherosclerotic disease | Nicholas J. Leeper | 2019-06-25 |
| 10316094 | Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance | Roy Louis Maute, Kipp Andrew Weiskopf, Aaron Michael Ring | 2019-06-11 |
| 10301387 | Methods for achieving therapeutically effective doses of anti-CD47 agents | Stephen Willingham, Maureen Howard, Jie Liu, Ravindra Majeti, Susan Sweeney Prohaska +2 more | 2019-05-28 |
| 10184004 | CD47 targeted therapies for the treatment of infectious disease | Kipp Andrew Weiskopf, Kim J. Hasenkrug, Cheryl A. Stoddart, Joseph M. McCune | 2019-01-22 |